Results 61 to 70 of about 103,766,681 (205)

Validation of replicative phenotyping to detect and assign HIV-1 resistance in clinical specimens [PDF]

, 2009
The ability of HIV-1 to develop resistance to antiretroviral drugs has limited the overall efficacy of combination therapy to suppress viral replication.
Louvel, Séverine
core   +1 more source

Longitudinal survey of condom use across a US Navy and Marine Corps shipboard deployment

BMJ Open, 2019
ObjectivesCondoms are highly effective in preventing sexually transmitted infections (STIs) but implementation is often inconsistent with use rarely examined across travel transition periods.
Judith Harbertson, Kimberly De Vera, Paul T Scott, Yuanzhang Li, Richard A Shaffer, Nelson L Michael, Braden R Hale   +6 more
doaj   +1 more source

Media communication in HIV/AIDS and STI : young people perspectives

, 2011
Background: Although recent developments of antiretroviral drugs for treating HIV/AIDS appear promising, prevention of infection is the only safeguard; and the key factor to preventing infection, be it of HIV or any other sexually transmitted disease, is
Razaghi, Kazem (R20892)
core  

The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV. [PDF]

, 2015
OBJECTIVES To describe the HIV care cascade for Switzerland in the year 2012. DESIGN/METHODS Six levels were defined: (i) HIV-infected, (ii) HIV-diagnosed, (iii) linked to care, (iv) retained in care, (v) on antiretroviral treatment (ART), and ...
Swiss HIV Cohort Study, Battegay, Manuel, Schmidt, Axel J, Furrer, Hansjakob, Vernazza, Pietro, Calmy, Alexandra, Cavassini, Matthias, Bernasconi, Enos, Vernazza, Pietro; https://orcid.org/, Kohler, Philipp, Ledergerber, Bruno, Kohler P, Calmy, A., Cavassini, M., Furrer H, Battegay M, Schmidt AJ, Vernazza P, Battegay, M., Vernazza, P., Calmy A, Cavassini M, Ledergerber, B., Schmidt, A.J., Ledergerber B, Furrer, H., Kohler, P., Bernasconi E, Bernasconi, E.   +28 more
core   +2 more sources

Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique

Virology Journal, 2011
The HIV/AIDS pandemic is primarily caused by HIV-1. Another virus type, HIV-2, is found mainly in West African countries. We hypothesized that population migration and mobility in Africa may have facilitated the introduction and spreading of HIV-2 in ...
Bhatt Nilesh, Tanuri Amilcar, Abreu Celina, Curvo Raphael, Walle Carla, Ismael Nalia, Meggi Bindiya, Costa Deise, Maueia Cremildo, Jani Ilesh V, Ferreira Orlando C   +10 more
doaj   +1 more source

HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update

Clinical Infectious Diseases
Abstract Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and ...
Charlotte Charpentier, Dirk Berzow, Quentin Le Hingrat, Rolf Kaiser, Perpetua Gomes, Ana Claudia Miranda, Florence Damond, Jade Ghosn, Jeroen J A van Kampen, Björn-Erik Ole Jensen, Michael Böhm, Annemarie M J Wensing, Diane Descamps, Martin Obermeier   +13 more
openaire   +3 more sources

Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis. [PDF]

, 2013
INTRODUCTION: There is conflicting evidence and practice regarding the use of the non-nucleoside reverse transcriptase inhibitors (NNRTI) efavirenz (EFV) and nevirapine (NVP) in first-line antiretroviral therapy (ART). METHODS: We systematically reviewed
Pillay, Prinitha, Prinitha Pillay (435496), Pillay Prinitha, Prinitha Pillay, Ford Nathan, Shubber Zara, Shubber, Zara, Ford, Nathan, Rashida A. Ferrand, Ferrand Rashida A., Nathan Ford, Ferrand, Rashida A, Nathan Ford (59436), Zara Shubber (279389), Rashida A. Ferrand (253679), Rashida A Ferrand, Zara Shubber   +16 more
core   +1 more source

HIV/AIDS and STD Semiannual Report Incident, Prevalent, and Cumulative AIDS Cases in Kansas as of ... by Date of Report HIV/AIDS in Kansas Biannual Report ... HIV/AIDS in Kansas Annual Report ...

, 2009
Contains Incident, Prevalent, and Cumulative AIDS Cases in Kansas as of ... by Date of Report "HIV/AIDS and STD Semiannual Report is a publication of the Kansas Department of Health and Environment with funding assistance from the Centers for Disease ...
HIV/AIDS Surveillance Program
core  

Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA

, 2010
BACKGROUND: Early initiation of combination antiretroviral therapy (ART) during primary HIV-1 infection may prevent the establishment of large viral reservoirs, possibly resulting in improved control of plasma viraemia rebound after ART cessation ...
Niederoest, B, Fischer, M., Battegay, Manuel, Günthard, Huldrych F, Fischer, M, Gianella, S., Weber, R, Vernazza, P, Cavassini, M., Gianella, S, Swiss HIV Cohort Study,, Bernasconi, E, Cavassini, M, Battegay, M., Vernazza, P., Joos, B., Rauch, A., Bernasconi, Enos, Weber, R., von Wyl, Viktor, Günthard, Huldrych F., Niederoest, B., Rauch, A, von Wyl, V., Hirschel, Bernard, Rauch, Andri, Joos, B, Günthard, H.F., Joos, Beda, Günthard, H F, Hirschel, B, Gianella, Sara, Niederoest, Barbara, Vernazza, Pietro, Battegay, M, Fischer, Marek, Weber, Rainer, von Wyl, V, Hirschel, B., Cavassini, Matthias, Bernasconi, E., Sara Gianella, Bernard Hirschel, Battegay M, Vernazza P, Viktor von Wyl, Swiss HIV Cohort Study, Andri Rauch, Rauch A, null null, Fischer M, Bernasconi E, Barbara Niederoest, Enos Bernasconi, Pietro Vernazza, Gianella S, Hirschel B, Cavassini M, Beda Joos, Rainer Weber, Marek Fischer, von Wyl V, Niederoest B, Manuel Battegay, Günthard HF, Huldrych F Günthard, Matthias Cavassini, Joos B, Weber R   +68 more
core   +1 more source

Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages

Life Science Alliance
The study shows that tuberculosis-driven glycolysis in macrophages promotes tunneling nanotube formation, thereby enhancing HIV-1 spread, highlighting metabolism as a target to limit viral dissemination.
Zoï Vahlas, Clara Deyts, Steven Fried, Myriam Ben Neji, Maxime Pingret, Natacha Faivre, Sarah C Monard, Quentin Hertel, Mariano Maio, Joaquina Barros, Alexandre Lucas, Thien Phong Vu Manh, Marcelo Corti, Renaud Poincloux, Fabien Blanchet, Brigitte Raynaud-Messina, Fabien Letisse, Olivier Neyrolles, Geanncarlo Lugo-Villarino, Luciana Balboa, Christel Vérollet   +20 more
doaj   +1 more source